The whole company currently only has a market capitalisation of $20m. It seems to me that just the veterinary market alone for a unique product like this that will make vaccinating large herds of animals faster, safer, easier and a lot more cost efficient. It would be worth a whole lot more than $20m to a large pharmaceutical co who could charge premium prices for such a unique product imo.
There now seems to be no impediment to it's use on animals.
Then there is the possibility of the human market....
- Forums
- ASX - By Stock
- needle free injection vaccine breakthrough
The whole company currently only has a market capitalisation of...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)